IceCure Medical Boosts Confidence with Nasdaq Compliance IceCure Medical Ltd has regained compliance with Nasdaq's listing requirements, providing a positive signal to investors. The company, known for its cryoablation systems, continues to develop innovative tumor treatment technologies. This marks a key milestone as it seeks FDA approval for its ProSense system, aiming to strengthen its market position.1